��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Analysis of Injection Site Reactions across Four Placebo Controlled Trials of Erenumab for Migraine Prevention

Topic Headache

Presentation(s) P4 - (-)

Poster/Presentation
Number 116

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
Brendan Davies, MD (University Hospital of North Staffordshi)	No disclosure on file
Hernan Picard	No disclosure on file
Frank Hong	No disclosure on file
	No disclosure on file
	No disclosure on file
Daniel D. Mikol, MD, PhD	Dr. Mikol has received personal compensation for serving as an employee of NervGen. Dr. Mikol has received personal compensation for serving as an employee of Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for NervGen. Dr. Mikol has stock in NervGen. Dr. Mikol has stock in Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with NervGen.
Jan Klatt, MD	No disclosure on file